The next-generation RNA therapeutics market is poised for strong growth as mRNA, siRNA, and antisense technologies enable innovative therapies for complex and previously untreatable diseases. The market growth is attributed to rising institutional funding and expanding applications of RNA platforms in oncology, rare genetic disorders, and infectious disease therapeutics.
The global real-time location systems market size was calculated at USD 5.23 billion in 2024 and is predicted to increase from USD 6.49 billion in 2025 to approximately USD 45.13 billion by 2034, expanding at a CAGR of 24.05% from 2025 to 2034. The market is driven by rapid urbanization, rising need for advanced security systems, rising use of smartphones and mobile gaming, and rapid growth in adoption in the healthcare segment.
The global myopia treatment devices market size accounted for USD 18.07 billion in 2024 and is predicted to increase from USD 19.49 billion in 2025 to approximately USD 38.51 billion by 2034, expanding at a CAGR of 7.86% from 2025 to 2034. This market is growing due to the rising prevalence of vision disorders among younger populations and the increasing adoption of advanced corrective technologies.
The psoriatic arthritis therapeutics drugs market is evolving rapidly with innovation in biosimilars, small molecules, and personalized medicine improving treatment outcomes. The market growth is attributed to rising psoriatic arthritis prevalence, expanding access to biologics and targeted oral therapies, and supportive regulatory approvals enhancing treatment adoption.
The global hyaluronic acid personal care products market size was estimated at USD 3.61 billion in 2024 and is predicted to increase from USD 3.92 billion in 2025 to approximately USD 8.34 billion by 2034, expanding at a CAGR of 8.74% from 2025 to 2034. The market for hyaluronic acid personal care products has experienced a massive spike in growth during recent years, reflecting increasing consumer awareness and demand for skincare and beauty products containing this popular ingredient. As we look to the future, the market is expected to continue its expansion, driven by innovations and expanding applications across the personal care industry.
The global flexible electronics in healthcare market size accounted for USD 7.00 billion in 2024 and is predicted to increase from USD 8.40 billion in 2025 to approximately USD 43.57 billion by 2034, expanding at a CAGR of 20.70% from 2025 to 2034. The rising prevalence of chronic diseases, growing demand for wearable health monitors, increasing consumer preference for biosensor-equipped smart clothing, and rapid technological innovation are expected to boost the growth of the global flexible electronics in healthcare market over the forecast period. Several prominent players are widely adopting effective strategies like new product launches and mergers to gain a competitive edge and strengthen their market share. Additionally, the market is expanding in emerging regions, particularly the Asia Pacific, fueled by the presence of key market players and the expansion of production & manufacturing capacity of flexible electronics.
The global glycyrrhiza glabra licorice root extract market size accounted for USD 2.15 billion in 2024 and is predicted to increase from USD 2.28 billion in 2025 to approximately USD 3.87 billion by 2034, expanding at a CAGR of 6.05% from 2025 to 2034. The market is experiencing significant growth due to the increasing demand for herbal and natural ingredients in pharmaceuticals, cosmetics, and food products. This growth is further supported by the anti-inflammatory, antioxidant, and antimicrobial properties of these ingredients. Additionally, the rising use of herbal products in skincare, respiratory health supplements, and functional foods is expected to drive market expansion.
The global vitamin B-complex ingredients market size accounted for USD 3.35 billion in 2024 and is predicted to increase from USD 3.49 billion in 2025 to approximately USD 5.01 billion by 2034, expanding at a CAGR of 4.11% from 2025 to 2034. Increasing awareness about vitamin B complex and its crucial functions in the body, prevalence of diseases due to low immunity, vitamin deficiency, and innovative healthcare product launches by several key players in the market are driving factors for the market.
The global reusable laparoscopic instruments market size accounted for USD 3.27 billion in 2024 and is predicted to increase from USD 3.49 billion in 2025 to approximately USD 6.28 billion by 2034, expanding at a CAGR of 6.74% from 2025 to 2034. The market is driven by the rising demand for minimally invasive surgeries, the increasing prevalence of chronic diseases, and the cost-effectiveness of reusable laparoscopic instruments.
The global rifaximin market size accounted for USD 1.84 billion in 2024 and is predicted to increase from USD 2.04 billion in 2025 to approximately USD 5.09 billion by 2034, expanding at a CAGR of 10.72% from 2025 to 2034. The increased awareness about effective treatment options for gastrointestinal disease and demand for non-systemic antibiotics, like rifaximin driving the market.
The global non-sterile liquids and suspensions market size accounted for USD 48.06 million in 2024 and is predicted to increase from USD 51.46 million in 2025 to approximately USD 95.25 million by 2034, expanding at a CAGR of 7.08% from 2025 to 2034. The market for non-sterile liquids and suspensions is driven by rising demand for oral medications, ease of administration, pediatric and geriatric preference, cost-effectiveness, expanding pharmaceutical production, and increasing prevalence of chronic diseases.
The global pulmonary alveolar proteinosis (PAP) drugs market size was estimated at USD 750.05 million in 2024 and is predicted to increase from USD 802.70 million in 2025 to approximately USD 1,478.22 million by 2034, expanding at a CAGR of 7.02% from 2025 to 2034. The market is experiencing significant growth due to the rising prevalence of rare lung disorders and a heightened focus on targeted therapies. This growth is further supported by advancements in biologics and the development of both inhaled and systemic treatment options. Additionally, an increase in clinical research and orphan drug designations is expected to further accelerate market expansion.
The global nefopam hydrochloride injection market size accounted for USD 120.06 billion in 2024 and is predicted to increase from USD 129 billion in 2025 to approximately USD 246.30 billion by 2034, expanding at a CAGR of 7.45% from 2025 to 2034. The increased demand for non-opioid analgesics is driving the adoption of nefopam hydrochloride injections, leading to an expansion of the market acceptability and availability. Additionally, the ongoing advancements in drug delivery systems are further contributing to the increasing adoption of nefopam hydrochloride injections globally, particularly in Europe, the Asia Pacific, and Latin America.
The global patient telemonitoring systems market is shaped by regulatory support and technological advancements in wearable and connected health devices.The growing rate of chronic diseases globally, technological advancements like AI/ML and its integration into healthcare systems, increasing shift to online consulting are driving factors of the patient telemonitoring systems market.
The global laser-based 3D bioprinting market size was calculated at USD 1.54 billion in 2024 and is predicted to increase from USD 1.79 billion in 2025 to approximately USD 7.11 billion by 2034, expanding at a CAGR of 16.53% from 2025 to 2034. The rapid growth of the laser-based 3D bioprinting market is driven by growing need for organ and tissue regeneration, pharmaceutical drug testing, and ongoing improvements in laser precision and biocompatible materials.
The global penicillin G acylase market size accounted for USD 150.05 million in 2024 and is predicted to increase from USD 158.39 million in 2025 to approximately USD 257.77 million by 2034, expanding at a CAGR of 5.56% from 2025 to 2034. The growing demand for semi-synthetic antibiotics, rapid advancements in enzyme immobilization technologies, growing demand for enzyme-based manufacturing processes, and increasing popularity of sustainable production methods are expected to drive the growth of the global market for penicillin G acylase over the forecast period. Several key players in the market are widely adopting effective strategies to expand their market share and gain a competitive edge. Additionally, the market is expanding in emerging regions, particularly North America, fuelled by increasing healthcare expenditure and a surge in research activities.
The global cardiotoxicity screening market size accounted for USD 2.84 billion in 2024 and is predicted to increase from USD 3.17 billion in 2025 to approximately USD 8.46 billion by 2034, expanding at a CAGR of 11.54% from 2025 to 2034. The increased demand for effective and precise cardiotoxicity screening methods is driving the global market. The growing awareness about drug safety is further contributing to this demand.
The global ceftazidime-avibactam market size accounted for USD 3.3 billion in 2024 and is predicted to increase from USD 3.56 billion in 2025 to approximately USD 7.15 billion by 2034, expanding at a CAGR of 8.05% from 2025 to 2034. The market for ceftazidime-avibactam is experiencing substantial growth due to the rising incidence of multidrug-resistant gram-negative infections, which is driving its demand in clinical settings. This demand is further reinforced by its effectiveness in treating complicated intra-abdominal and urinary tract infections. Increasing hospital utilization and heightened awareness of antimicrobial resistance are expected to accelerate market expansion.
The global cables for endoscopes market size accounted for USD 1.26 billion in 2024 and is predicted to increase from USD 1.37 billion in 2025 to approximately USD 3.00 billion by 2034, expanding at a CAGR of 9.06% from 2025 to 2034. The market is showing steady growth with the developments in imaging technology used in the medical field, growing demand for minimally invasive surgery, and spending growth in healthcare and healthcare infrastructure, indicating an overall positive prognosis for the market.
The global biopsy bag market size accounted for USD 1.25 billion in 2024 and is predicted to increase from USD 1.37 billion in 2025 to approximately USD 3.11 billion by 2034, expanding at a CAGR of 9.54% from 2025 to 2034. The market is driven by rising cancer prevalence, increasing biopsy procedures, and growing demand for safe and contamination-free specimen handling.
The global pentoxifylline drug market size accounted for USD 450.06 million in 2024 and is predicted to increase from USD 479.49 million in 2025 to approximately USD 848.00 million by 2034, expanding at a CAGR of 6.54% from 2025 to 2034. The market is experiencing substantial growth due to the increasing prevalence of peripheral artery diseases and chronic blood circulation disorders. This demand is further supported by pentoxifylline’s effectiveness in improving blood flow and alleviating the symptoms of vascular conditions. Additionally, its growing relevance in managing diabetic neuropathy and other microcirculatory complications is expected to drive market expansion.
The global PEGylation proteins technology market size accounted for USD 4.56 billion in 2024 and is predicted to increase from USD 4.89 billion in 2025 to approximately USD 9.17 billion by 2034, expanding at a CAGR of 7.24% from 2025 to 2034. The market growth is attributed to rising demand for long-acting biologics that enhance patient adherence and reduce treatment burden through PEGylation-enabled drug delivery.
The global intellectual and development disability care market size was estimated at USD 24.60 billion in 2024 and is predicted to increase from USD 26.29 billion in 2025 to approximately USD 47.72 billion by 2034, expanding at a CAGR of 6.85% from 2025 to 2034. The market is growing steadily as healthcare systems place a greater emphasis on inclusivity, personalized care, and long-term support services.
The global fibromyalgia treatment market size was calculated at USD 3.49 billion in 2024 and is predicted to increase from USD 3.63 billion in 2025 to approximately USD 5.16 billion by 2034, expanding at a CAGR of 3.97% from 2025 to 2034. The growing adoption of combination therapies, biologics, and personalized medicine approaches enhances treatment outcomes, driving the market’s growth in emerging nations. The three drugs that are FDA-approved specifically for fibromyalgia include pregabalin (Lyrica), duloxetine (Cymbalta), and milnacipran (Savella). Additionally, North America dominated the market, fuelled by the high healthcare expenditure and accessibility of advanced treatments.
The global electrolyte tablet market size accounted for USD 5.12 billion in 2024 and is predicted to increase from USD 5.38 billion in 2025 to approximately USD 8.33 billion by 2034, expanding at a CAGR of 4.99% from 2025 to 2034. The electrolyte tablet market is experiencing significant growth, with its size expected to increase substantially in the coming years. Driven by rising health consciousness and hydration needs, it is projected to expand rapidly.
The global soybean oil pharma grade market size accounted for USD 1.25 billion in 2024 and is predicted to increase from USD 1.34 billion in 2025 to approximately USD 2.54 billion by 2034, expanding at a CAGR of 7.34% from 2025 to 2034. The market is driven by rising demand for natural excipients in drug formulations and growing use in nutraceuticals and soft gel capsules.
The global nigella sativa extract market size accounted for USD 1.7 billion in 2024 and is predicted to increase from USD 1.88 billion in 2025 to approximately USD 4.59 billion by 2034, expanding at a CAGR of 10.45% from 2025 to 2034. The market is expanding due to growing awareness of Nigella sativa extracts and their potential medicinal properties, ongoing research that shows its efficiency, and a strong supply chain.
The global multi-chamber bags for parenteral nutrition market size accounted for USD 1.55 billion in 2024 and is predicted to increase from USD 1.67 billion in 2025 to approximately USD 3.21 billion by 2034, expanding at a CAGR of 7.54% from 2025 to 2034. The market is growing due to increasing incidence of chronic diseases and gastrointestinal conditions, advances in safer, more user-friendly bag design, and the enhancement of home-based, nutritional care, clearly upward.
The global dunaliella salina extract market size accounted for USD 200.06 million in 2024 and is predicted to increase from USD 217.27 million in 2025 to approximately USD 456.52 million by 2034, expanding at a CAGR of 8.60% from 2025 to 2034. The market is experiencing significant growth due to the rising demand for natural antioxidants and carotenoids in nutraceuticals and cosmetics. This demand is supported by the high beta-carotene content of the extract and its associated health benefits in skincare and dietary supplements. Additionally, the increasing use of personal food products and anti-aging treatments is expected to further boost market expansion.
The global cranberry capsules market size accounted for USD 1.25 billion in 2024 and is predicted to increase from USD 1.36 billion in 2025 to approximately USD 2.94 billion by 2034, expanding at a CAGR of 8.94% from 2025 to 2034. The market is growing due to rising consumer awareness of its benefits in supporting urinary tract health and overall wellness.
The Asia Pacific pain relief oil market size was calculated at USD 1.36 million in 2024 and is predicted to increase from USD 1.45 million in 2025 to approximately USD 2.46 million by 2034, expanding at a CAGR of 6.11% from 2025 to 2034. The pain relief oil market is a rapidly growing sector within the healthcare industry, driven by increasing demand for natural and effective pain management solutions.
The global gastroparesis treatment market size accounted for USD 6.63 billion in 2024 and is predicted to increase from USD 6.94 billion in 2025 to approximately USD 10.45 billion by 2034, expanding at a CAGR of 4.65% from 2025 to 2034. The market is steadily growing, driven by the rising prevalence of diabetes-related gastric dysfunction, a growing need for minimally invasive devices and new prokinetics, and increased awareness, suggesting the market is on a path for a sustainable, upward trend.
The global fibroblast growth factors (FGFs) market size accounted for USD 3.54 billion in 2024 and is predicted to increase from USD 3.84 billion in 2025 to approximately USD 8.03 billion by 2034, expanding at a CAGR of 8.54% from 2025 to 2034. The market is experiencing significant growth, driven by increasing research in regenerative medicine and tissue repair. This growth is further supported by expanding applications in wound healing, stem cell therapy, and cancer research. Additionally, advancements in biologics and an increase in clinical studies are anticipated to accelerate market expansion.
The global prostaglandin analogs market size accounted for USD 3.54 billion in 2024 and is predicted to increase from USD 3.75 billion in 2025 to approximately USD 6.38 billion by 2034, expanding at a CAGR of 6.06% from 2025 to 2034. The market growth is attributed to the rising glaucoma prevalence and increasing adoption of early treatment protocols supported by global health initiatives.
The global epidermal growth factors (EGFs) market size accounted for USD 1.19 billion in 2024 and is predicted to increase from USD 1.24 billion in 2025 to approximately USD 1.72 billion by 2034, expanding at a CAGR of 3.75% from 2025 to 2034. The increased demand for advanced skincare products, wound healing treatments, and regenerative medicines is driving the global market. The growing innovations in personalized skincare solutions are further contributing to the market growth. The increased demand for advanced skincare products.
The global eliquis market size accounted for USD 20.15 billion in 2024 and is predicted to increase from USD 21.09 billion in 2025 to approximately USD 31.74 billion by 2034, expanding at a CAGR of 4.65% from 2025 to 2034. The market is significantly expanding due to increasing incidences of fatal illnesses like CVDs, cancer, which can be treated effectively by the Eliquis molecule, which is supported by regulatory bodies as well.
The U.S. pantoprazole market size was estimated at USD 743.96 million in 2024 and is predicted to increase from USD 785.46 million in 2025 to approximately USD 1,302.87 million by 2034, expanding at a CAGR of 5.76% from 2025 to 2034. The market is growing due to rising cases of gastroesophageal reflux disease (GERD) and other acid-related disorders worldwide.
The global long-acting injectables (LAIs) market size accounted for USD 16.94 billion in 2024 and is predicted to increase from USD 19.14 billion in 2025 to approximately USD 57.26 billion by 2034, expanding at a CAGR of 12.95% from 2025 to 2034. The market is gaining traction due to improved adherence, reduced dosing frequency, and providing stable pharmacokinetics for chronic and specialty conditions. Also, an obvious reason for this rise is the advancement in drug delivery systems.
The global baby swabs market size was calculated at USD 1.31 billion in 2024 and is predicted to increase from USD 1.43 billion in 2025 to approximately USD 3.19 billion by 2034, expanding at a CAGR of 9.32% from 2025 to 2034. The heightened parental awareness of hygiene, demand for eco-friendly materials, and the convenience of usage are expected to drive the growth of the global baby swabs market over the forecast period. Several key players in the market are increasingly adopting various strategies to boost the sales of baby cotton swabs, such as mergers, acquisitions, and new product launches, to expand their market share and gain a competitive edge. Additionally, the market is expanding in emerging regions, particularly North America, fuelled by the presence of key market players and growing demand for hygiene products.
The global smart fall detection device market size was calculated at USD 1.25 billion in 2024 and is predicted to increase from USD 1.41 billion in 2025 to approximately USD 4.18 billion by 2034, expanding at a CAGR of 12.83% from 2025 to 2034. The market is significantly fuelling due to an increasing ageing population who need continues monitoring and postoperative care, advancement in sensor technology like IoT, AI/ML integration with fall detection devices, and enhanced awareness about preventive measures in the healthcare sector.
The global pantoprazole market size was estimated at USD 2.51 billion in 2024 and is predicted to increase from USD 2.65 billion in 2025 to approximately USD 4.34 billion by 2034, expanding at a CAGR of 5.64% from 2025 to 2034. The rising prevalence of gastroesophageal reflux disease (GERD), increasing regulatory approvals, and rapid advancements in drug delivery systems are expected to drive the growth of the global pantoprazole market over the forecast period. Several key players in the industry are widely adopting effective strategies like new product launches and mergers to expand their market share and gain a competitive edge. Additionally, the market is expanding in emerging regions, particularly North America, fuelled by the presence of key market players and rising increasing prevalence of gastroesophageal reflux disease (GERD).
The global diabetes nutrition market size accounted for USD 12.64 billion in 2024 and is predicted to increase from USD 13.54 billion in 2025 to approximately USD 25.22 billion by 2034, expanding at a CAGR of 7.15% from 2025 to 2034. The market is on the rise due to the increase of diabetes worldwide, the global population is aging, and urbanization and demand for dietary products designed for consumers with diabetes, ranging from low-sugar to low-carbohydrate.
The global glucosamine market size accounted for USD 1.10 billion in 2024 and is predicted to increase from USD 1.16 billion in 2025 to approximately USD 1.90 billion by 2034, expanding at a CAGR of 5.63% from 2025 to 2034. The market growth is attributed to increasing consumer awareness of joint health and the rising adoption of preventive healthcare practices globally.
The global HT supplement (50X) market size was calculated at USD 1.85 billion in 2024 and is predicted to increase from USD 2.02 billion in 2025 to approximately USD 4.55 billion by 2034, expanding at a CAGR of 9.42% from 2025 to 2034. The market for HT supplement is growing due to increased interest in biotechnology research and the prior use of cellular science, cell culture, and protein expression, and increased funding in the life sciences sector research, clearly being an area of high growth, use, and demand.
The global adult clinical nutrition market size was estimated at USD 21.56 billion in 2024 and is predicted to increase from USD 22.62 billion in 2025 to approximately USD 34.82 billion by 2034, expanding at a CAGR of 4.91% from 2025 to 2034. The adult clinical nutrition market is experiencing growth due to the aging population, the rising prevalence of chronic diseases, and greater awareness of specialized nutritional needs.
The global lysozyme market size accounted for USD 569.12 million in 2024 and is predicted to increase from USD 610.21 million in 2025 to approximately USD 1,142.78 million by 2034, expanding at a CAGR of 7.22% from 2025 to 2034. The market is driven by its wide applications in pharmaceuticals, food preservation, and biotechnology. Known for its antibacterial properties, lysozyme plays a critical role in extending product shelf life and supporting human health.
The global medical fluoropolymers market size accounted for USD 573.64 million in 2024 and is predicted to increase from USD 627.62 million in 2025 to approximately USD 1,409.97 million by 2034, expanding at a CAGR of 9.41% from 2025 to 2034. The market is driven by the rising demand for minimally invasive surgeries, biocompatible materials, and high-performance medical devices.
The global bacterial endotoxin testing market size was calculated at USD 1.26 billion in 2024 and is predicted to increase from USD 1.38 billion in 2025 to approximately USD 3.02 billion by 2034, expanding at a CAGR of 9.14% from 2025 to 2034. The market is growing due to increasing regulatory demands for the safety and quality of pharmaceutical and medical device products.
The global antibody ELISA kits for tropical infectious disease market size was estimated at USD 2.39 billion in 2024 and is predicted to increase from USD 2.54 billion in 2025 to approximately USD 4.41 billion by 2034, expanding at a CAGR of 6.32% from 2025 to 2034. The market for antibody ELISA kits for tropical infectious diseases is witnessing increasing momentum, driven by public health investment at the global level, increased surveillance programs, and access to diagnostic tests thanks to more widely available and emerging technologies.
The global pain relief oil market size accounted for USD 4.55 billion in 2024 and is predicted to increase from USD 4.83 billion in 2025 to approximately USD 8.19 billion by 2034, expanding at a CAGR of 6.05% from 2025 to 2034. The market is driven by rising demand for natural and herbal remedies, increasing cases of chronic pain, and growing awareness of alternative therapies.
The global esophageal cancer molecular diagnosis market size accounted for USD 1.52 billion in 2024 and is predicted to increase from USD 1.64 billion in 2025 to approximately USD 3.3 billion by 2034, expanding at a CAGR of 8.05% from 2025 to 2034. The market is experiencing significant growth due to the rising prevalence of esophageal cancer and the growing demand for early and accurate detection. This growth is further supported by advancements in biomarker research and non-invasive diagnostic technologies. Additionally, the increasing adoption of personalized medicine is expected to accelerate market expansion in the coming years.
The global indigo carmine market size accounted for USD 51.58 billion in 2024 and is predicted to increase from USD 54.07 billion in 2025 to approximately USD 82.92 billion by 2034, expanding at a CAGR of 4.87% from 2025 to 2034. The market’s unique coloring properties and stability make it a preferred choice in applications requiring vivid, long-lasting color. With increasing demand in medical diagnostics and sustainable textile solutions, the market continues to expand steadily.
The global medical aesthetic treatments market is witnessing rapid growth due to increasing demand for non-invasive cosmetic procedures and technological innovation. The market is experiencing significant growth due to the rising demand for minimally invasive cosmetic procedures and an increased focus on physical appearance. Technological advancements in lasers, injectables, and skin rejuvenation devices are further driving this market expansion. Additionally, the growing acceptance of aesthetic treatments among both the younger and aging populations is expected to boost market growth in the coming years.
The global anti-thyroid peroxidase antibody test kit market size accounted for USD 150.07 million in 2024 and is predicted to increase from USD 162.92 million in 2025 to approximately USD 341.19 million by 2034, expanding at a CAGR of 8.56% from 2025 to 2034. The market for anti-thyroid peroxidase antibody test kits continues to grow due to an increasing prevalence of autoimmune thyroid disease, advances in diagnostic technology, and increased health care spending and awareness, leading to a strong upward trajectory for the market.
The global segmented flow analyzer market size accounted for USD 1.36 billion in 2024 and is predicted to increase from USD 1.50 billion in 2025 to approximately USD 3.73 billion by 2034, expanding at a CAGR of 10.62% from 2025 to 2034. The market growth is attributed to rising regulatory enforcement for environmental monitoring and increasing demand for high-throughput, automated analytical solutions.
The global mosquito-borne infections testing market size was calculated at USD 27.11 billion in 2024 and is predicted to increase from USD 28.15 billion in 2025 to approximately USD 39.52 billion by 2034, expanding at a CAGR of 3.84% from 2025 to 2034. driven by increasing awareness of mosquito-borne diseases and advancements in diagnostic technologies.
The global insulin drugs and delivery devices market size accounted for USD 23.72 billion in 2024 and is predicted to increase from USD 25.53 billion in 2025 to approximately USD 49.39 billion by 2034, expanding at a CAGR of 7.61% from 2025 to 2034. The market is experiencing significant growth due to the increasing global prevalence of diabetes, which is driving the demand for effective insulin therapies and advanced delivery devices. This market growth is further supported by innovations in insulin formulations and the development of user-friendly devices such as pens, pumps, and inhalers. Additionally, the rising adoption of smart insulin delivery systems is expected to accelerate market growth in the coming years.
The global pill timer market size accounted for USD 1.24 billion in 2024 and is predicted to increase from USD 1.35 billion in 2025 to approximately USD 2.94 billion by 2034, expanding at a CAGR of 9.02% from 2025 to 2034. The pill timer market is growing with an aging population, increasing chronic disease prevalence, and rising medication adherence awareness. Technological innovations like smart, IoT-enabled devices and app integration further strengthen the market growth.
The global container closure integrity testing service market size accounted for USD 1.37 billion in 2024 and is predicted to increase from USD 1.50 billion in 2025 to approximately USD 3.34 billion by 2034, expanding at a CAGR of 9.32% from 2025 to 2034. The container closure integrity testing service market is driven by increasing regulatory compliance, rising demand for sterile pharmaceutical packaging, and the need to ensure product safety, sterility, and quality throughout the drug manufacturing and distribution process.
The global ENFit syringes market size accounted for USD 800.05 million in 2024 and is predicted to increase from USD 849.97 million in 2025 to approximately USD 1,465.54 million by 2034, expanding at a CAGR of 6.24% from 2025 to 2034. The ENFit syringes market is growing due to stricter patient safety regulations, increasing chronic disease cases, and rising demand for accurate, secure enteral feeding solutions in hospital and homecare environments.
The global dehydration monitoring devices market size accounted for USD 3.56 billion in 2024 and is predicted to increase from USD 3.86 billion in 2025 to approximately USD 8.08 billion by 2034, expanding at a CAGR of 8.54% from 2025 to 2034. The market is experiencing substantial growth due to increasing awareness of health risks related to fluid imbalances, as well as rising cases of dehydration among the elderly and pediatric populations. This growth is further supported by advancements in wearable and non-invasive monitoring technologies.
The global blood glucose monitoring market size was calculated at USD 16.46 billion in 2024 and is predicted to increase from USD 17.20 billion in 2025 to approximately USD 25.53 billion by 2034, expanding at a CAGR of 4.49% from 2025 to 2034. The growth of the market is driven by advancements in technology and the rising prevalence of diabetes worldwide.
The global artificial organs and bionic implants market size was estimated at USD 37.60 billion in 2024 and is predicted to increase from USD 41.19 billion in 2025 to approximately USD 93.69 billion by 2034, expanding at a CAGR of 9.56% from 2025 to 2034. The growth of the market is attributed to the rise in chronic diseases, an aging population, shortages of organs, and increasing rates of accidental injuries. Ongoing technological advancements, including 3D bioprinting, neural bionics, biohybrid organs, AI integration, and miniaturized, self-powered implants, are supporting market growth.
The global RFID blood refrigerators and freezers market size accounted for USD 331.96 million in 2024 and is predicted to increase from USD 375.91 million in 2025 to approximately USD 1,151.02 million by 2034, expanding at a CAGR of 13.24% from 2025 to 2034. The market is experiencing significant growth due to the increasing demand for safe and effective blood storage and tracking solutions. Rising adoption of automation and real-time inventory management systems in blood banks and hospitals also support market growth.
The global disposable urine bags market size accounted for USD 1.56 billion in 2024 and is predicted to increase from USD 1.67 billion in 2025 to approximately USD 3.11 billion by 2034, expanding at a CAGR of 7.15% from 2025 to 2034.The market is growing due to rising awareness about hygiene and increasing demand for convenient, portable sanitation solutions in the healthcare sector.
The global diabetes care devices market size was calculated at USD 64.54 billion in 2024 and is predicted to increase from USD 68.57 billion in 2025 to approximately USD 118.34 billion by 2034, expanding at a CAGR of 6.25% from 2025 to 2034. The growth of the diabetes care devices market is driven by the increasing prevalence of diabetes and advancements in medical devices. The rising demand for effective diabetes management solutions further contributes to market growth.
The global digital pathology slide scanner market size accounted for USD 1.19 billion in 2024 and is predicted to increase from USD 1.39 billion in 2025 to approximately USD 5.70 billion by 2034, expanding at a CAGR of 16.95% from 2025 to 2034. The market is growing due to the increasing adoption of AI-driven diagnostic tools and rising demand for remote pathology consultations.
The global hepatocyte growth factors (HGFs) market size was estimated at USD 72.76 million in 2024 and is predicted to increase from USD 76.66 million in 2025 to approximately USD 122.65 million by 2034, expanding at a CAGR of 5.36% from 2025 to 2034. The market is experiencing significant growth due to the rising incidence of liver disorders and increased research into regenerative medicine. Advancements in cell-based therapies, which show promise for tissue repair and organ regeneration, and growing clinical applications of HGFs for liver and kidney diseases are expected to drive market growth in the coming years.
The global hERG screening market size accounted for USD 1.16 billion in 2024 and is predicted to increase from USD 1.29 billion in 2025 to approximately USD 3.32 billion by 2034, expanding at a CAGR of 11.10% from 2025 to 2034. The rising development of innovative drug formulations is driving the global hERG screening market.
The global healthcare supply chain management market size accounted for USD 3.75 billion in 2024 and is predicted to increase from USD 3.95 billion in 2025 to approximately USD 6.32 billion by 2034, expanding at a CAGR of 5.35% from 2025 to 2034. The growth of the market is driven by rising demand for medical products and transparency in supply chains. Additionally, the rising adoption of AI, IoT, cloud, and blockchain technologies to enhance security in supply chains contributes to market growth.
The global genotyping assays market size was calculated at USD 19.45 billion in 2024 and is predicted to increase from USD 22.14 billion in 2025 to approximately USD 71.16 billion by 2034, expanding at a CAGR of 13.85% from 2025 to 2034. The growth of the genotyping assays market is driven by rising demand for personalized medicine, increasing prevalence of genetic disorders, advancements in genomics technologies, and expanding applications in drug development.
The global platelet-derived growth factors market size accounted for USD 1.3 billion in 2024 and is predicted to increase from USD 1.42 billion in 2025 to approximately USD 3.23 billion by 2034, expanding at a CAGR of 9.54% from 2025 to 2034. The growth of the platelet-derived growth factors market is driven by rising demand for regenerative medicine, advancements in wound healing therapies, and growing applications in tissue engineering and cell therapy.
The global implantable insulin pumps market size was estimated at USD 5.24 billion in 2024 and is predicted to increase from USD 5.79 billion in 2025 to approximately USD 14.27 billion by 2034, expanding at a CAGR of 10.54% from 2025 to 2034. The market for implantable insulin pumps is experiencing substantial growth, driven by the increasing prevalence of diabetes and the demand for precise continuous insulin delivery. Advancements in drug delivery systems and a growing preference for minimally invasive procedures and long-term treatment options are likely to contribute to market growth.
The global blood transfusion diagnostics market size accounted for USD 4.98 billion in 2024 and is predicted to increase from USD 5.28 billion in 2025 to approximately USD 8.79 billion by 2034, expanding at a CAGR of 5.84% from 2025 to 2034. The growth of the blood transfusion diagnostics market is driven by the increasing number of chronic blood disorders and more blood transfusion procedures. Improvements in high-sensitivity screening methods, such as NAT, PCR, and AI, alongside global blood safety campaigns and better healthcare infrastructure, are contributing to market expansion.
The global lip augmentation market size accounted for USD 7.50 billion in 2024 and is predicted to increase from USD 8.09 billion in 2025 to approximately USD 15.96 billion by 2034, expanding at a CAGR of 7.84% from 2025 to 2034. The lip augmentation market has been experiencing significant growth, driven by evolving beauty standards and advancements in cosmetic procedures. As more individuals seek to enhance their facial aesthetics, the demand for lip augmentation treatments continues to rise.
The global laser capture microdissection market size was calculated at USD 203.15 million in 2024 and is predicted to increase from USD 220.60 million in 2025 to approximately USD 463.14 million by 2034, expanding at a CAGR of 8.59% from 2025 to 2034. The growth of the laser capture microdissection market is driven by rising demand for precision diagnostics and personalized medicine across advanced and emerging healthcare systems.
The global nucleic acid aptamers market size was calculated at USD 257.93 million in 2024 and is predicted to increase from USD 302.44 million in 2025 to approximately USD 1,267.63 million by 2034, expanding at a CAGR of 17.26% from 2025 to 2034. The increasing investments in research and development activities related to aptamers are driving the growth of the market. The demand for targeted therapies has been increasing, driving innovation and development of nucleic acid aptamers, fueling the market growth.
The immuno-oncology antibodies markets report analyzes key trends, market size, and major players shaping the future of cancer treatment. The market is experiencing significant growth due to the increasing prevalence of cancer and the shift toward targeted therapies. This market’s growth is further fostered by advancements in monoclonal and bispecific antibodies, which enhance the immune system's response against tumors. Additionally, the rise in clinical trials and approvals for novel antibodies is expected to accelerate market expansion in the coming years.
The global hyperpigmentation disorder treatment market size accounted for USD 5.78 billion in 2024 and is predicted to increase from USD 6.19 billion in 2025 to approximately USD 11.54 billion by 2034, expanding at a CAGR of 7.16% from 2025 to 2034. The growth of the market is attributed to the rising occurrence of skin pigmentation disorders such as melasma and dyschromia, increased interest in non-invasive cosmetic dermatology, and advances in laser, topical, and AI-based therapies.
The global liposomal supplements market size was estimated at USD 349.92 million in 2024 and is predicted to increase from USD 377.39 million in 2025 to approximately USD 745.02 million by 2034, expanding at a CAGR of 7.85% from 2025 to 2034. The market growth is attributed to rising consumer demand for high-bioavailability supplements supported by clinical evidence and regulatory validation of liposomal delivery systems.
The U.S. radiopharmaceutical therapies market size accounted for USD 1.71 billion in 2024 and is predicted to increase from USD 1.92 billion in 2025 to approximately USD 6.80 billion by 2034, expanding at a CAGR of 15.05% from 2025 to 2034. The market is growing due to the increasing cancer prevalence and rising adoption of targeted nuclear medicine for precise and minimally invasive treatments.
The global inactivated vaccines market size accounted for USD 42.97 billion in 2024 and is predicted to increase from USD 45.44 billion in 2025 to approximately USD 75.09 billion by 2034, expanding at a CAGR of 5.74% from 2025 to 2034. The market is experiencing significant growth due to an increasing emphasis on preventive healthcare and the rising incidence of infectious diseases. The market growth is further fueled by the proven safety, stability, and suitability of inactivated vaccines for immunocompromised individuals. Additionally, ongoing advancements in vaccine manufacturing and government immunization programs are expected to support continued market growth.
The global injectable cytotoxic drugs market size accounted for USD 19.48 billion in 2024 and is predicted to increase from USD 20.69 billion in 2025 to approximately USD 35.71 billion by 2034, expanding at a CAGR of 6.25% from 2025 to 2034. The injectable cytotoxic drugs market is driven by the increasing cancer prevalence, rising demand for targeted chemotherapy, and growing adoption of injectable oncology treatments.
The global induced pluripotent stem cells market size accounted for USD 1.93 billion in 2024 and is predicted to increase from USD 2.13 billion in 2025 to approximately USD 5.12 billion by 2034, expanding at a CAGR of 10.25% from 2025 to 2034. The market growth is attributed to the increasing demand for patient-specific cell therapies and disease models driven by advancements in reprogramming technologies and regenerative medicine.
The global deoxycholic acid obesity drugs market size accounted for USD 486.14 million in 2024 and is predicted to increase from USD 555.07 million in 2025 to approximately USD 1,830.89 million by 2034, expanding at a CAGR of 14.18% from 2025 to 2034. The deoxycholic acid obesity treatment market is driven by growing demand for non invasive fat-reduction methods, growing body contouring awareness, and increasing associated clinic practice worldwide, all of which are working together to support a strong upward trajectory of the identified market overall.
The global artificial intelligence and analytics in surgery market size accounted for USD 238.15 million in 2024 and is predicted to increase from USD 299.45 million in 2025 to approximately USD 2,352.8 million by 2034, expanding at a CAGR of 25.74% from 2025 to 2034. The market is expanding due to advancements in AI technology, its precise results in the healthcare sector, lack of skilled surgeons, and offerings of AI, like scalability, efficiency, accurate diagnosis, and precise data analysis of medical imaging, which reduces errors and burden on the existing healthcare infrastructure by streamlining workflows.
The global glucose tolerance test market size accounted for USD 51.56 billion in 2024 and is predicted to increase from USD 56.76 billion in 2025 to approximately USD 134.83 billion by 2034, expanding at a CAGR of 10.09% from 2025 to 2034. The market is experiencing significant growth due to the rising prevalence of diabetes and prediabetes. The growing awareness of health and routine screening practices further supports market growth. Additionally, technological advancements in diagnostic devices are expected to contribute to market expansion in the coming years.
The global GI stool testing market size accounted for USD 2.93 billion in 2024 and is predicted to increase from USD 3.09 billion in 2025 to approximately USD 5.02 billion by 2034, expanding at a CAGR of 5.53% from 2025 to 2034. The GI stool testing market is growing rapidly, driven by the increasing prevalence of gastrointestinal disorders, greater awareness for preventive health, and advances in home-based, non-invasive tests such ass molecular, AI-enhanced, and including some advanced immunoassay tests.
The autism clinics market is witnessing substantial growth driven by increasing autism prevalence, early screening initiatives, and personalized treatment options. Clinics are integrating AI tools, multidisciplinary care, and digital platforms to enhance therapy effectiveness. The growth of the autism clinics market is driven by rising awareness of early diagnosis and growing demand for personalized, multidisciplinary care solutions.
The global spatial transcriptomics market size accounted for USD 410.46 million in 2024 and is predicted to increase from USD 469.36 million in 2025 to approximately USD 1,569.03 million by 2034, expanding at a CAGR of 14.35% from 2025 to 2034. The market is experiencing significant growth because of the increasing demand for high-resolution molecular profiling in complex tissues. Additionally, a greater focus on cancer research, drug discovery, and developmental biology accelerated this market’s growth. Advancements in single-cell analysis and spatial genomics technologies are expected to support the continued expansion of the market in the coming years.
The global cardiac troponin market size accounted for USD 3.89 billion in 2024 and is predicted to increase from USD 4.3 billion in 2025 to approximately USD 10.51 billion by 2034, expanding at a CAGR of 10.45% from 2025 to 2034. The cardiac troponin market is growing quickly due to the increasing global prevalence of cardiovascular diseases. The rising demand for point-of-care testing and high-sensitivity assays further support market growth.
The global cardiac mapping market size accounted for USD 2.37 billion in 2024 and is predicted to increase from USD 2.62 billion in 2025 to approximately USD 6.51 billion by 2034, expanding at a CAGR of 10.63% from 2025 to 2034. The market is growing due to the rising prevalence of cardiac arrhythmia and the increasing demand for advanced diagnostic and treatment technologies.
The global brugada syndrome market size accounted for USD 1.28 billion in 2024 and is predicted to increase from USD 1.35 billion in 2025 to approximately USD 2.25 billion by 2034, expanding at a CAGR of 5.79% from 2025 to 2034. The increased disease awareness, advancements in diagnostics, and growing emphasis on personalized care are expected to boost the growth of the market during the forecast period.
The global artificial intelligence in bioinformatics market size was calculated at USD 8.80 billion in 2024 and is predicted to increase from USD 10.06 billion in 2025 to approximately USD 33.52 billion by 2034, expanding at a CAGR of 14.31% from 2025 to 2034. The increased demand for personalized medicines is driving the growth of the artificial intelligence in bioinformatics market. Rising investments in drug discovery & development further contributes to market growth.
The global orthopedic braces and support, casting and splints market size accounted for USD 7.53 billion in 2024 and is predicted to increase from USD 8.05 billion in 2025 to approximately USD 14.75 billion by 2034, expanding at a CAGR of 6.97% from 2025 to 2034. The growth of the orthopedic braces & support, casting & splints market is growing steadily due to the increasing incidences of musculoskeletal disorders and sports injuries. An ageing population, increasing spending on healthcare, and advances in material science and smart device technology further contribute to market growth.
The global exosome isolation market size was estimated at USD 413.91 million in 2024 and is predicted to increase from USD 462.08 million in 2025 to approximately USD 1,244.80 million by 2034, expanding at a CAGR of 11.64% from 2025 to 2034. The exosome isolation market is experiencing rapid growth, driven by rising interest in exosome-based diagnostics and therapeutics. As biomedical research advances, the development of efficient, scalable, and precise isolation techniques also increases.
The global B-cell lymphoma market size accounted for USD 5.08 billion in 2024 and is predicted to increase from USD 5.44 billion in 2025 to approximately USD 10 billion by 2034, expanding at a CAGR of 7.00% from 2025 to 2034. The market is experiencing significant growth due to the rising prevalence of B-cell lymphoma and the increasing demand for targeted cancer therapies. Additionally, advancements in immunotherapies such as CAR-T cell therapy and monoclonal antibodies have broadened treatment options. The growing focus on personalized medicine and rising clinical trials are expected to accelerate market growth in the coming years.
The global cholesterol testing products market size accounted for USD 23.57 billion in 2024 and is predicted to increase from USD 25.42 billion in 2025 to approximately USD 50.15 billion by 2034, expanding at a CAGR of 7.84% from 2025 to 2034. The demand for cholesterol testing products is increasing due to the rising prevalence of cardiovascular diseases, which is likely to boost the growth of the market during the forecast period.
The global in-vitro inflammatory bowel disease diagnostics market size was calculated at USD 1.74 billion in 2024 and is predicted to increase from USD 1.84 billion in 2025 to approximately USD 3.02 billion by 2034, expanding at a CAGR of 5.64% from 2025 to 2034. The in-vitro inflammatory bowel disease diagnostics market is driven by rising IBD prevalence, advancements in diagnostic technologies, and increasing demand for personalized medicine.
The global vendor neutral archive (VNA) market size accounted for USD 3.72 billion in 2024 and is predicted to increase from USD 3.91 billion in 2025 to approximately USD 6.16 billion by 2034, expanding at a CAGR of 5.18% from 2025 to 2034. The rising volume of medical imaging data is driving the demand for vendor neutral archive (VNA), which is boosting the growth of the market. The rising need for seamless data exchange and integration across different healthcare departments further supports market growth.
The global lactose intolerance treatment market size accounted for USD 33.9 billion in 2024 and is predicted to increase from USD 36.9 billion in 2025 to approximately USD 79.08 billion by 2034, expanding at a CAGR of 8.84% from 2025 to 2034. The lactose intolerance treatment market is growing steadily due to an increasing global incidence of lactose intolerance, increasing awareness of digestive health, and the increasing availability of lactose-free foods, enzyme supplements, and probiotics.
The global kidney transplant market size accounted for USD 9.27 billion in 2024 and is predicted to increase from USD 9.92 billion in 2025 to approximately USD 18.29 billion by 2034, expanding at a CAGR of 7.03% from 2025 to 2034. The market is witnessing significant growth because of the rising incidence of end-stage renal disease, increased success rates of transplant procedures, advances in immunosuppressive therapies, and improved surgical techniques. Additionally, rising organ donation programs are expected to support continued market expansion.
The global kidney stone retrieval devices market size accounted for USD 3.66 billion in 2024 and is predicted to increase from USD 3.93 billion in 2025 to approximately USD 7.52 billion by 2034, expanding at a CAGR of 7.47% from 2025 to 2034. The growth of the market is driven by the rising prevalence of kidney stone globally, which boosts the demand for efficient and technologically advanced retrieval solutions. Kidney stone retrieval devices are essential tools used in minimally invasive urological procedures to remove or break down kidney stones.
The global thermal cycler market size accounted for USD 1.06 billion in 2024 and is predicted to increase from USD 1.15 billion in 2025 to approximately USD 2.39 billion by 2034, expanding at a CAGR of 8.47% from 2025 to 2034. The growth of the market is driven by the rising importance of thermal cycler in life science research. The growing demand for high-performance thermal cyclers is contributing to the market growth.
The global stromal vascular fraction market size accounted for USD 1.54 billion in 2024 and is predicted to increase from USD 1.73 billion in 2025 to approximately USD 5.02 billion by 2034, expanding at a CAGR of 12.54% from 2025 to 2034. The stromal vascular fraction market is witnessing rapid growth, driven by the rising demand for regenerative medicine and stem cell–based therapies, advances in automated isolation technologies, increased demand for minimally invasive procedures, and progress being made in clinical research.
The global polycystic ovarian syndrome treatment market size was estimated at USD 4.84 billion in 2024 and is predicted to increase from USD 5.16 billion in 2025 to approximately USD 9.21 billion by 2034, expanding at a CAGR of 6.64% from 2025 to 2034. The market is witnessing substantial growth because of the rising prevalence of hormonal and lifestyle-related disorders, increased awareness of early diagnosis, and the adoption of combination therapies. Advances in hormonal drugs and personalized treatments are expected to sustain this growth in the upcoming years.
The global mesotherapy market size accounted for USD 764.46 million in 2024 and is predicted to increase from USD 820.57 million in 2025 to approximately USD 1,552.28 million by 2034, expanding at a CAGR of 7.34% from 2025 to 2034. The growth of the mesotherapy market is attributed to the rising demand for minimally invasive procedures and increased awareness of aesthetic treatments.
The global cardiac valvulotome market size accounted for USD 115.87 billion in 2024 and is predicted to increase from USD 121.34 billion in 2025 to approximately USD 184.51 billion by 2034, expanding at a CAGR of 4.77% from 2025 to 2034. The growth of the market is driven by the rising prevalence of heart valve-related conditions and increasing demand for minimally invasive procedures. The growing awareness about the importance and benefits of cardiac valvulotomes in minimally invasive procedures further supports market expansion.
The global ablation devices market size accounted for USD 9.90 billion in 2024 and is predicted to increase from USD 10.84 billion in 2025 to approximately USD 24.62 billion by 2034, expanding at a CAGR of 9.54% from 2025 to 2034. The ablation devices market is driven by the rising prevalence of chronic diseases, growing demand for minimally invasive procedures, and continuous technological advancements.
The global viral vectors based gene therapy for non-human primates market size accounted for USD 1.3 billion in 2024 and is predicted to increase from USD 1.5 billion in 2025 to approximately USD 5.46 billion by 2034, expanding at a CAGR of 15.44% from 2025 to 2034. It is expected to grow at a compound annual growth rate (CAGR) of xx% from 2025 to 2034. The increased prevalence of genetic disease and demand for personalized medicines are driving the growth of the market.
The global syphilis immunoassay diagnostics market size accounted for USD 578.93 million in 2024 and is predicted to increase from USD 611 million in 2025 to approximately USD 992.65 million by 2034, expanding at a CAGR of 5.54% from 2025 to 2034. The market is driven by increasing syphilis prevalence, higher public health incentives, government screening initiatives, and a high adoption rate of rapid point-of-care/immunoassay technology.
The global oligonucleotides market size accounted for USD 4.23 billion in 2024 and is predicted to increase from USD 4.79 billion in 2025 to approximately USD 14.54 billion by 2034, expanding at a CAGR of 13.14% from 2025 to 2034. The oligonucleotides market is driven by rising demand for gene-based therapies, advancements in molecular diagnostics, and increased research in genomics and personalized medicine.
The next-gen delivery systems for genetic drug market is accelerating with breakthroughs in delivery technologies such as lipid nanoparticles, viral vectors, and exosomes. These innovations are improving the precision, safety, and efficiency of gene and RNA-based therapies across various therapeutic areas. This market is growing due to its ability to enhance targeted delivery, stability, and safety of genetic therapies like mRNA, siRNA, and CRISPR.
The global bovine blood plasma derivatives market size was estimated at USD 1.25 billion in 2024 and is predicted to increase from USD 1.36 billion in 2025 to approximately USD 3.00 billion by 2034, expanding at a CAGR of 9.15% from 2025 to 2034. The market is experiencing substantial growth due to the increasing use of bovine blood plasma derivatives in the production of high-protein supplements, animal feeds, and pharmaceuticals. Advancements in processing and purification techniques and a growing focus on animal health are expected to further drive market growth.
Phase Ib gene editing trials market growth driven by in vivo CRISPR base editing, lipid nanoparticle delivery & early cardiovascular and rare disease therapies. The market growth is attributed to the increasing prevalence of genetic disorders and rapid advancements in CRISPR and precision gene-editing technologies.
Cutting-edge biologics, AI diagnostics, microneedles & personalized skincare fuel the next gen dermatology treatments market through 2030. The growth of the next-gen dermatology treatments market is driven by the rising demand for personalized skincare and the growing aesthetics awareness. Ongoing advancements in targeted therapies and minimally invasive procedures further support market growth.
The global bimekizumab (BIMZELX) market size accounted for USD 1.24 billion in 2024 and is predicted to increase from USD 1.50 billion in 2025 to approximately USD 8.10 billion by 2034, expanding at a CAGR of 20.64% from 2025 to 2034. The growth of the market is driven by the rising approvals for bimekizumab across several countries are enhancing accessibility, making it a major contender in the immunology biologics space.
Market insights on genetic editing for ASCVD, featuring CRISPR based therapies targeting PCSK9 & ANGPTL3 to transform cardiovascular disease treatment. The genetic editing for ASCVD market is propelled by advanced research infrastructure, strong regulatory support, and growing demand for personalized cardiovascular therapies.
The global nuclear magnetic resonance spectroscopy market size accounted for USD 1.59 billion in 2024 and is predicted to increase from USD 1.68 billion in 2025 to approximately USD 2.73 billion by 2034, expanding at a CAGR of 5.54% from 2025 to 2034. The adoption of nuclear magnetic resonance (NMR) spectroscopy has increased in industries like pharmaceuticals and biotechnology, driving the global nuclear magnetic resonance spectroscopy market.
Net zero pharma supply chain market focus on green logistics, PPAs for cold chain, sustainable packaging, and lifecycle carbon reporting. The market growth is attributed to increasing regulatory mandates, climate-aligned investment strategies, and rising adoption of digital platforms that enable end-to-end carbon visibility across pharmaceutical supply chains.
The global marine pharmaceutical market size accounted for USD 6.15 billion in 2024 and is predicted to increase from USD 6.47 billion in 2025 to approximately USD 10.26 billion by 2034, expanding at a CAGR of 5.25% from 2025 to 2034. This market is growing due to the increasing demand for novel bioactive compounds, especially derived from marine organisms, for use in drug discovery and therapeutic applications.
Contract manufacturing partnerships (CMOs) market analysis outsourcing trends, continuous manufacturing, regulatory compliance and quality assurance. The growth of the market is driven by the increased complexity of drug development, which boosts the demand for specialized expertise.
The biopharma clinical trials market is witnessing robust growth fueled by increasing R&D investments, the rise of biologics, and demand for faster time-to-market. Innovations like decentralized trials, AI-powered patient recruitment, and adaptive trial designs are transforming how biopharma companies conduct clinical studies, enhancing efficiency and success rates across therapeutic areas. The market is experiencing significant growth due to the rising prevalence of chronic and rare diseases, which drives the need for innovative therapies. Additionally, the increasing adoption of decentralized trials and digital technologies is projected to accelerate market expansion in the coming years.
The Advanced Technologies in Marine Drug Development Market focuses on innovative tools like AI-driven screening, genomics, and bioprocessing to discover novel therapeutics from marine sources. These technologies are transforming drug discovery by tapping into the vast potential of ocean biodiversity.The growth of the advanced technologies in marine drug development market is driven by the rising demand for natural therapeutics, ongoing technological advancements, and the untapped potential of marine biodiversity.
The tech-enabled pharmaceutical facilities market leverages digital technologies such as AI, robotics, and advanced analytics to optimize drug manufacturing processes. This market is growing rapidly as pharma companies aim for greater efficiency, precision, and real-time monitoring in production environments. The tech-enabled pharmaceutical facilities market is developing fast due to demands for growing automation, AI-based manufacturing integration, and increasing quality drug production. This development is fueled by digital transformation, compliance with regulations, and an increased global need for today's healthcare.
The global veterinary antihistamines market size accounted for USD 1.25 billion in 2024 and is predicted to increase from USD 1.32 billion in 2025 to approximately USD 2.12 billion by 2034, expanding at a CAGR of 5.43% from 2025 to 2034. The veterinary antihistamines market is experiencing rapid growth because of increasing pet ownership, rising prevalence of allergies among animals, and improvements in veterinary care. The rising demand for safe and effective allergy medications for companion animals contributes to the market's continual growth.
The global veterinary parasiticides market size accounted for USD 12.94 billion in 2024 and is predicted to increase from USD 13.63 billion in 2025 to approximately USD 21.77 billion by 2034, expanding at a CAGR of 5.34% from 2025 to 2034. The growth of the veterinary parasiticides market is driven by the increased pet ownership, growth in livestock population, and increased awareness about animal health and wellness.
The global veterinary analgesics/anti-inflammatory (NSAIDs) market size accounted for USD 2.43 billion in 2024 and is predicted to increase from USD 2.59 billion in 2025 to approximately USD 4.58 billion by 2034, expanding at a CAGR of 6.54% from 2025 to 2034. The market is experiencing substantial growth, driven by an increasing pet population and a rising awareness of animal health. Additionally, the growing incidence of osteoarthritis and post-surgical pain and advancements in drug formulations are expected to support market expansion in the coming years.
The global phentermine hydrochloride market size was calculated at USD 567.10 million in 2024 and is predicted to increase from USD 606.80 million in 2025 to approximately USD 1,115.57 million by 2034, expanding at a CAGR of 7.00% from 2025 to 2034. The growth of the market is attributed to the rising rates of obesity and the increasing awareness of health risks associated with it.
The global veterinary antibiotics market size accounted for USD 5.26 billion in 2024 and is predicted to increase from USD 5.43 billion in 2025 to approximately USD 7.19 billion by 2034, expanding at a CAGR of 3.18% from 2025 to 2034. The increasing prevalence of livestock diseases and growing awareness of pet health and wellness are driving the growth of the veterinary antibiotics market. The rising demand for precision medicine further support market expansion.
The global complex rehab technology market size accounted for USD 12.28 billion in 2024 and is predicted to increase from USD 13.09 billion in 2025 to approximately USD 23.76 billion by 2034, expanding at a CAGR of 6.82% from 2025 to 2034. The complex rehab technology market is growing rapidly due to the increasing need for customized mobility and assistive solutions for individuals with complex medical needs.
The global multiomics market size accounted for USD 2.81 billion in 2024 and is predicted to increase from USD 3.24 billion in 2025 to approximately USD 11.79 billion by 2034, expanding at a CAGR of 15.42% from 2025 to 2034. The market is experiencing rapid growth due to the increasing prevalence of chronic diseases, which is creating the need for early and accurate diagnostics. The growth of the market is further driven by a heightened focus on personalized medicine and advancements in high-throughput technologies. Additionally, the rising demand for integrated approaches to understand disease mechanisms is contributing to market expansion.
The global wegovy market size accounted for USD 2.44 billion in 2024 and is predicted to increase from USD 3.07 billion in 2025 to approximately USD 24.53 billion by 2034, expanding at a CAGR of 25.96% from 2025 to 2034. The market is experiencing significant growth due to rising global obesity rates and effective clinical outcomes in weight loss and cardiovascular risk reduction. The rising demand for GLP-1 therapy to manage diabetes and obesity further supports market growth.
The global mounjaro market size accounted for USD 14.18 billion in 2024 and is predicted to increase from USD 16.82 billion in 2025 to approximately USD 78.51 billion by 2034, expanding at a CAGR of 18.67% from 2025 to 2034.
The cell and gene therapy infrastructure and delivery models market is growing rapidly as the industry shifts toward scalable, decentralized manufacturing, advanced cold-chain logistics, and integrated clinical delivery to meet rising demand for personalized therapies. The cell and gene therapy (CGT) infrastructure & delivery models market continues to experience robust growth, driven by the increased clinical success rates of cell and gene therapies and increased healthcare expenditure.
The global next-generation biologics market size was estimated at USD 110.58 billion in 2024 and is predicted to increase from USD 122.24 billion in 2025 to approximately USD 301.22 billion by 2034, expanding at a CAGR of 10.54% from 2025 to 2034. The market is witnessing rapid growth because of the increasing demand for targeted and more effective therapies, along with innovations such as bispecific antibody drugs, conjugates, and gene and cell therapies. These developments are driving market expansion by offering improved efficacy, reduced side effects, and personalized treatment options across various chronic and rare diseases.
The global lipase inhibitors obesity drugs market size accounted for USD 1.25 billion in 2024 and is predicted to increase from USD 1.43 billion in 2025 to approximately USD 4.94 billion by 2034, expanding at a CAGR of 14.72% from 2025 to 2034. The lipase inhibitors obesity drugs market is growing as obesity increases, awareness for weight management is also on the rise, and people are demanding non-invasive treatment options. In addition, government health programs and new advances in drug formulation will progress the overall market.
The cell and gene therapy patient access and reimbursement market focuses on payer strategies, reimbursement pathways, and innovative payment models (e.g., annuity, outcomes-based) to ensure patient access to costly cell and gene treatments. The cell and gene therapy patient access and reimbursement market is driven by innovative payment models, regulatory support, and growing demand for high-cost, transformative therapies.
The global ventricular tachycardia (VT) ablation market is expected to grow at a notable CAGR from 2025 to 2034. The rising prevalence of cardiovascular conditions due to aging population and changing lifestyle factors is driving the growth of the ventricular tachycardia (VT) ablation market.
The global venous leg ulcer market size accounted for USD 2.25 billion in 2024 and is predicted to increase from USD 2.57 billion in 2025 to approximately USD 8.47 billion by 2034, expanding at a CAGR of 14.18% from 2025 to 2034. The market is experiencing substantial growth driven by the rising prevalence of chronic venous insufficiency (CVI) and an aging population, creating the need for effective wound care solutions. Advancements in compression therapies, bioactive therapies, and regenerative treatments are improving healing outcomes and reducing recurrence rates, thereby supporting market growth.
The global peripheral nerve injury market size accounted for USD 1.69 billion in 2024 and is predicted to increase from USD 1.82 billion in 2025 to approximately USD 3.59 billion by 2034, expanding at a CAGR of 7.84% from 2025 to 2034. The market is growing due to the rising incidence of traumatic injuries and increasing advancements in nerve repair and regeneration technologies.
The global medical isotope production market size accounted for USD 4.35 billion in 2024 and is predicted to increase from USD 4.71 billion in 2025 to approximately USD 9.69 billion by 2034, expanding at a CAGR of 8.34% from 2025 to 2034. The medical isotope production market is gaining momentum due to increasing demand for nuclear medicine in cancer and cardiac diagnostics, supportive government initiatives, and improvements in cyclotron and reactor-based production methods that are growing the market globally.
The U.S. clinical trial management system market size accounted for USD 720 million in 2024 and is predicted to increase from USD 810 million in 2025 to approximately USD 2,400 million by 2034, expanding at a CAGR of 12.79% from 2025 to 2034. The U.S. clinical trial management system market is growing due to ongoing increases in R&D investment, growing complexities in clinical trials, evolving regulatory requirements, the continuing progress of the digitization that is taking place in healthcare, and the rising burden of chronic disease across the globe.
The global human biospecimens market size accounted for USD 12.42 billion in 2024 and is predicted to increase from USD 13.40 billion in 2025 to approximately USD 26.45 billion by 2034, expanding at a CAGR of 7.85% from 2025 to 2034. The market is growing due to increasing demand for personalized medicine, biomedical research, and advancements in diagnostic and drug development technologies.
The pan-tumor oncology treatment market is gaining momentum with the emergence of therapies targeting genetic mutations across cancer types, supported by advancements in companion diagnostics and personalized medicine approaches. The pan-tumor oncology market is rapidly gaining traction as researchers and clinicians recognize its potential to treat various cancers more effectively through targeted therapies. This approach's growing popularity reflects a shift toward personalized medicine, promising improved outcomes across multiple tumor types.
The oncology combination therapy market is witnessing significant growth as healthcare providers increasingly adopt combination regimens to overcome resistance, enhance efficacy, and personalize treatment across various cancer types. The market is experiencing significant growth due to the increasing burden of cancer and the rising resistance to monotherapy, which are boosting the demand for combination treatments. Ongoing advancements in immunotherapy, targeted therapies, and personalized medicine are enhancing the efficacy of combination therapies and survival outcomes for patients.
The global next-generation cancer therapeutics market size was estimated at USD 86.20 billion in 2024 and is predicted to increase from USD 92.54 billion in 2025 to approximately USD 175.20 billion by 2034, expanding at a CAGR of 7.35% from 2025 to 2034. The growth of the next-generation cancer therapeutics market is driven by the rising development of novel immunotherapy, increasing prevalence of cancer, and substantial government funding. The rising demand for personalized treatments and advances in mRNA technology are expected to drive market growth in the coming years.
The Checkpoint Inhibitor Drugs Market is expanding with growing adoption of immunotherapies that target immune checkpoints like PD-1, PD-L1, and CTLA-4, offering improved survival outcomes in oncology. The checkpoint inhibitor drugs market is growing at a fast rate since cancer cases are increasing, new regimens are emerging, and further approvals and increased use in varied treatment frameworks.
Single-dose gene therapy market sees rapid growth driven by advancements in genetic engineering and increasing demand for lasting cures. The single-dose gene therapy market is growing as biopharmaceutical companies are focusing on developing new gene therapies that last longer. The rising approval for AAV-based therapies and the increasing prevalence of rare diseases further support market growth.
Explore trends and innovations shaping the next-gen cardiovascular treatments market, driving advanced care for heart disease worldwide. The market is experiencing significant growth due to the increased burden of cardiovascular diseases, which has boosted the demand for advanced targeted therapies. Innovation in gene therapy, regenerative medicine, and personalized approaches further support market expansion. Additionally, the growing adoption of minimally invasive procedures and AI-powered diagnostics is expected to fuel market growth in the coming years.
